Breaking News Instant updates and real-time market news.

LDOS

Leidos

$105.70 /

-2.15 (-1.99%)

, LHX

L3Harris Technologies

$184.51 /

-1.26 (-0.68%)

12:10
02/16/21
02/16
12:10
02/16/21
12:10

Leidos slips after Spruce Point short report says $1B 'wasted,' flaws concealed

Shares of Leidos Holdings (LDOS) are down about 2% to $105.81 in early afternoon trading after Spruce Point Capital Management issued a short report in which it tells investors that it sees "up to 60% downside risk" for the stock. In the report, the short-selling research firm argues that Leidos "wasted $1 billion" on the acquisition of L3Harris' (LHX) Security Detection & Automation business and "has potentially misled investors on its financial benefits." In addition, Spruce Point claims that "evidence suggests that under CEO Roger Krone's leadership, Leidos is concealing numerous product defects from investors, including faulty explosive detection systems at airports, ports and borders." Reference Link

LDOS

Leidos

$105.70 /

-2.15 (-1.99%)

LHX

L3Harris Technologies

$184.51 /

-1.26 (-0.68%)

  • 16

    Feb

  • 23

    Feb

  • 10

    Mar

LDOS Leidos
$105.70 /

-2.15 (-1.99%)

11/03/20 Credit Suisse
Leidos price target lowered to $120 from $131 at Credit Suisse
09/23/20 Barclays
Barclays upgrades Leidos to Overweight, sees above peer growth in 2021
09/23/20 Barclays
Leidos upgraded to Overweight from Equal Weight at Barclays
09/22/20 JPMorgan
Leidos upgraded to Overweight on bottomed estimates at JPMorgan
LHX L3Harris Technologies
$184.51 /

-1.26 (-0.68%)

02/01/21 Credit Suisse
L3Harris Technologies price target lowered to $200 from $210 at Credit Suisse
02/01/21 Citi
L3Harris Technologies price target lowered to $225 from $235 at Citi
01/07/21 Baird
L3Harris Technologies downgraded to Neutral from Outperform at Baird
12/15/20
Fly Intel: Top five analyst downgrades

TODAY'S FREE FLY STORIES

Recommendations
UBS price target raised to CHF 20 from CHF 17 at Morgan Stanley » 15:38
10/27/21
10/27
15:38
10/27/21
15:38
UBS

UBS

$18.08 /

+0.12 (+0.67%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBS UBS
$18.08 /

+0.12 (+0.67%)

UBS UBS
$18.08 /

+0.12 (+0.67%)

15:10 Today RBC Capital
UBS price target raised to CHF 20 from CHF 19 at RBC Capital
14:59 Today Barclays
UBS price target raised to CHF 16.50 from CHF 15 at Barclays
14:09 Today Credit Suisse
UBS price target raised to CHF 19.50 from CHF 18.50 at Credit Suisse
13:44 Today Deutsche Bank
UBS price target raised to CHF 19 from CHF 18 at Deutsche Bank
UBS UBS
$18.08 /

+0.12 (+0.67%)

UBS UBS
$18.08 /

+0.12 (+0.67%)

UBS UBS
$18.08 /

+0.12 (+0.67%)

Recommendations
Societe Generale price target raised to EUR 36 from EUR 35 at Morgan Stanley » 15:38
10/27/21
10/27
15:38
10/27/21
15:38
SCGLY

Societe Generale

$6.70 /

-0.005 (-0.07%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCGLY Societe Generale
$6.70 /

-0.005 (-0.07%)

SCGLY Societe Generale
$6.70 /

-0.005 (-0.07%)

10/18/21 Barclays
Societe Generale price target raised to EUR 25 from EUR 23 at Barclays
10/18/21 Deutsche Bank
Societe Generale price target raised to EUR 36 from EUR 34 at Deutsche Bank
10/04/21 Credit Suisse
Societe Generale price target raised to EUR 35 from EUR 34 at Credit Suisse
09/10/21 JPMorgan
BNP Paribas downgraded to Neutral from Overweight at JPMorgan
Recommendations
Schroders price target raised to 3,930 GBp from 3,700 GBp at Morgan Stanley » 15:37
10/27/21
10/27
15:37
10/27/21
15:37
SHNWF

Schroders

$49.48 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHNWF Schroders
$49.48 /

+ (+0.00%)

10/07/21 Morgan Stanley
Schroders price target lowered to 3,700 GBp from 3,890 GBp at Morgan Stanley
08/04/21 RBC Capital
Schroders price target raised to 3,600 GBp from 3,400 GBp at RBC Capital
08/03/21 UBS
Schroders price target raised to 4,250 GBp from 4,175 GBp at UBS
08/03/21 Morgan Stanley
Schroders price target raised to 3,890 GBp from 3,810 GBp at Morgan Stanley
Recommendations
Renishaw price target raised to 5,800 GBp from 5,500 GBp at Morgan Stanley » 15:37
10/27/21
10/27
15:37
10/27/21
15:37
RNSHF

Renishaw

$76.88 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RNSHF Renishaw
$76.88 /

+ (+0.00%)

10/26/21 Stifel
Renishaw upgraded to Buy at Stifel after 'very strong' Q1 update
10/26/21 Stifel
Renishaw upgraded to Buy from Hold at Stifel
07/27/21 Goldman Sachs
Renishaw upgraded to Buy from Neutral at Goldman Sachs
07/20/21 Barclays
Renishaw price target lowered to 4,695 GBp from 5,185 GBp at Barclays
RNSHF Renishaw
$76.88 /

+ (+0.00%)

Recommendations
Kion Group price target raised to EUR 90 from EUR 83 at Morgan Stanley » 15:36
10/27/21
10/27
15:36
10/27/21
15:36
KIGRY

Kion Group

$27.06 /

+1.46 (+5.70%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KIGRY Kion Group
$27.06 /

+1.46 (+5.70%)

14:19 Today JPMorgan
Kion Group price target raised to EUR 99 from EUR 96 at JPMorgan
10/12/21 Morgan Stanley
Kion Group price target raised to EUR 83 from EUR 77 at Morgan Stanley
07/30/21 JPMorgan
Kion Group price target raised to EUR 96 from EUR 72 at JPMorgan
07/06/21 Deutsche Bank
Kion Group price target raised to EUR 90 from EUR 85 at Deutsche Bank
Recommendations
Deutsche Boerse price target raised to EUR 159.80 at Morgan Stanley » 15:36
10/27/21
10/27
15:36
10/27/21
15:36
DBOEY

Deutsche Boerse

$16.76 /

-0.01 (-0.06%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DBOEY Deutsche Boerse
$16.76 /

-0.01 (-0.06%)

DBOEY Deutsche Boerse
$16.76 /

-0.01 (-0.06%)

10/21/21 Deutsche Bank
Deutsche Boerse price target raised to EUR 179 from EUR 178 at Deutsche Bank
10/13/21 Morgan Stanley
Deutsche Boerse price target raised to EUR 158.10 at Morgan Stanley
08/12/21 Kepler Cheuvreux
Deutsche Boerse upgraded to Buy from Hold at Kepler Cheuvreux
08/03/21 Deutsche Bank
Deutsche Boerse price target raised to EUR 178 from EUR 176 at Deutsche Bank
Recommendations
Bureau Veritas price target raised to EUR 30 from EUR 29 at Morgan Stanley » 15:35
10/27/21
10/27
15:35
10/27/21
15:35
BVRDF

Bureau Veritas

$31.21 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BVRDF Bureau Veritas
$31.21 /

+ (+0.00%)

08/03/21 Deutsche Bank
Bureau Veritas price target raised to EUR 29 from EUR 26 at Deutsche Bank
08/03/21 RBC Capital
Bureau Veritas price target raised to EUR 26 from EUR 24 at RBC Capital
08/02/21 Credit Suisse
Bureau Veritas price target raised to EUR 30.50 from EUR 26.50 at Credit Suisse
07/29/21 Societe Generale
Bureau Veritas price target raised to EUR 32 from EUR 29 at Societe Generale
Recommendations
Alfa Laval price target raised to SEK 327 from SEK 312 at Morgan Stanley » 15:35
10/27/21
10/27
15:35
10/27/21
15:35
ALFVY

Alfa Laval

$40.25 /

+1.8 (+4.68%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALFVY Alfa Laval
$40.25 /

+1.8 (+4.68%)

15:08 Today RBC Capital
Alfa Laval price target raised to SEK 400 from SEK 370 at RBC Capital
09/28/21 Morgan Stanley
Alfa Laval price target raised to SEK 312 from SEK 300 at Morgan Stanley
09/06/21 Credit Suisse
Alfa Laval downgraded to Neutral from Outperform at Credit Suisse
08/03/21 Barclays
Alfa Laval price target raised to SEK 320 from SEK 270 at Barclays
Options
Boot Barn options imply 7.9% move in share price post-earnings » 15:34
10/27/21
10/27
15:34
10/27/21
15:34
BOOT

Boot Barn

$100.00 /

-0.77 (-0.76%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOOT Boot Barn
$100.00 /

-0.77 (-0.76%)

BOOT Boot Barn
$100.00 /

-0.77 (-0.76%)

10/22/21 UBS
Boot Barn price target raised to $109 from $94 at UBS
10/20/21 Cowen
Boot Barn price target raised to $110 from $97 at Cowen
10/20/21 Citi
Boot Barn price target raised to $120 from $110 at Citi
08/17/21 Citi
Boot Barn added to 'Value Creators' SMID Focus List at Citi
BOOT Boot Barn
$100.00 /

-0.77 (-0.76%)

BOOT Boot Barn
$100.00 /

-0.77 (-0.76%)

Recommendations
GM share price reaction to guidance 'looks excessive,' says Citi » 15:28
10/27/21
10/27
15:28
10/27/21
15:28
GM

General Motors

$54.77 /

-2.61 (-4.55%)

Citi analyst Itay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$54.77 /

-2.61 (-4.55%)

GM General Motors
$54.77 /

-2.61 (-4.55%)

09:30 Today Wedbush
Other bulk deals to follow and further benefit Tesla, says Wedbush
10/25/21 Wedbush
Hertz mega deal another 'feather in the cap' for Tesla, says Wedbush
10/22/21 Barclays
General Motors price target raised to $70 from $68 at Barclays
10/21/21 JPMorgan
General Motors price target raised to $80 from $77 at JPMorgan
GM General Motors
$54.77 /

-2.61 (-4.55%)

GM General Motors
$54.77 /

-2.61 (-4.55%)

GM General Motors
$54.77 /

-2.61 (-4.55%)

GM General Motors
$54.77 /

-2.61 (-4.55%)

Options
Noodles & Company options imply 7.7% move in share price post-earnings » 15:25
10/27/21
10/27
15:25
10/27/21
15:25
NDLS

Noodles & Company

$12.46 /

-0.2 (-1.58%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NDLS Noodles & Company
$12.46 /

-0.2 (-1.58%)

NDLS Noodles & Company
$12.46 /

-0.2 (-1.58%)

10/06/21 Piper Sandler
Noodles & Company price target raised to $15 from $14 at Piper Sandler
10/05/21 Stephens
Noodles & Company initiated with an Overweight at Stephens
05/26/21 Sidoti
Noodles & Company initiated with a Buy at Sidoti
03/11/21 Piper Sandler
Noodles & Company upgraded to Overweight from Neutral at Piper Sandler
NDLS Noodles & Company
$12.46 /

-0.2 (-1.58%)

  • 16
    Dec
  • 01
    Dec
NDLS Noodles & Company
$12.46 /

-0.2 (-1.58%)

Options
ArcelorMittal call volume above normal and directionally bullish » 15:25
10/27/21
10/27
15:25
10/27/21
15:25
MT

ArcelorMittal

$33.37 /

-0.545 (-1.61%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

10/14/21
Fly Intel: Top five analyst downgrades
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 KeyBanc
ArcelorMittal downgraded to Sector Weight from Overweight at KeyBanc
10/14/21 Credit Suisse
ArcelorMittal upgraded to Outperform from Neutral at Credit Suisse
MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

Periodicals
Feds probing Novartis over Entresto marketing, doctor compensation, Stat says » 15:23
10/27/21
10/27
15:23
10/27/21
15:23
NVS

Novartis

$83.08 /

-1.77 (-2.09%)

Federal investigators…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$83.08 /

-1.77 (-2.09%)

NVS Novartis
$83.08 /

-1.77 (-2.09%)

14:22 Today JPMorgan
Novartis price target lowered to CHF 80 from CHF 84 at JPMorgan
10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
NVS Novartis
$83.08 /

-1.77 (-2.09%)

NVS Novartis
$83.08 /

-1.77 (-2.09%)

NVS Novartis
$83.08 /

-1.77 (-2.09%)

NVS Novartis
$83.08 /

-1.77 (-2.09%)

On The Fly
Fly Intel: What to watch in Comcast earnings report » 15:20
10/27/21
10/27
15:20
10/27/21
15:20
CMCSA

Comcast

$52.88 /

-0.87 (-1.62%)

, CHTR

Charter

$720.54 /

-7.42 (-1.02%)

, ATUS

Altice USA

$17.11 /

-0.48 (-2.73%)

, ROKU

Roku

$318.50 /

-5.53 (-1.71%)

, VZIO

Vizio

$20.40 /

+0.21 (+1.04%)

Media giant,…

ShowHide Related Items >><<
CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

CHTR Charter
$720.54 /

-7.42 (-1.02%)

ATUS Altice USA
$17.11 /

-0.48 (-2.73%)

ROKU Roku
$318.50 /

-5.53 (-1.71%)

VZIO Vizio
$20.40 /

+0.21 (+1.04%)

CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

10/13/21 Morgan Stanley
Morgan Stanley says Comcast dropping network a modest near-term negative for MSG
10/12/21 Deutsche Bank
Comcast price target lowered to $64 from $68 at Deutsche Bank
10/11/21
Fly Intel: Top five analyst downgrades
10/11/21 Raymond James
Comcast downgraded to Market Perform from Outperform at Raymond James
CHTR Charter
$720.54 /

-7.42 (-1.02%)

10/12/21 Deutsche Bank
Deutsche downgrades Charter on end to favorable cable environment
10/12/21 Deutsche Bank
Charter downgraded to Hold from Buy at Deutsche Bank
10/11/21
Fly Intel: Top five analyst downgrades
10/11/21 Raymond James
Charter downgraded to Market Perform from Outperform at Raymond James
ATUS Altice USA
$17.11 /

-0.48 (-2.73%)

10/19/21 Citi
Altice USA price target lowered to $21 from $34 at Citi
10/15/21 Pivotal Research
Altice USA price target lowered to $30 from $47 at Pivotal Research
10/12/21 Deutsche Bank
Deutsche downgrades Altice USA on end to favorable cable environment
10/12/21 Deutsche Bank
Altice USA downgraded to Hold from Buy at Deutsche Bank
ROKU Roku
$318.50 /

-5.53 (-1.71%)

10/21/21 Stephens
Roku sits in 'more enviable' position in fight over YouTube TV, says Stephens
10/07/21 Stephens
Comcast-branded Smart TV Launch in U.S. 'likely imminent,' says Stephens
09/30/21 Cleveland Research
Roku initiated with a Buy at Cleveland Research
09/27/21 BofA
Roku selloff overdone as streaming lead remains, says BofA
VZIO Vizio
$20.40 /

+0.21 (+1.04%)

10/11/21 Stephens
Vizio CTO exit not tied to any recent underperformance, says Stephens
10/07/21 Stephens
Comcast-branded Smart TV Launch in U.S. 'likely imminent,' says Stephens
09/20/21
Fly Intel: Top five analyst initiations
09/20/21 Cannonball Research
Vizio initiated with a Neutral at Cannonball Research
CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

CHTR Charter
$720.54 /

-7.42 (-1.02%)

ATUS Altice USA
$17.11 /

-0.48 (-2.73%)

ROKU Roku
$318.50 /

-5.53 (-1.71%)

VZIO Vizio
$20.40 /

+0.21 (+1.04%)

  • 24
    Aug
  • 25
    Mar
CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

CHTR Charter
$720.54 /

-7.42 (-1.02%)

ROKU Roku
$318.50 /

-5.53 (-1.71%)

VZIO Vizio
$20.40 /

+0.21 (+1.04%)

CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

CHTR Charter
$720.54 /

-7.42 (-1.02%)

ATUS Altice USA
$17.11 /

-0.48 (-2.73%)

ROKU Roku
$318.50 /

-5.53 (-1.71%)

VZIO Vizio
$20.40 /

+0.21 (+1.04%)

CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

ATUS Altice USA
$17.11 /

-0.48 (-2.73%)

ROKU Roku
$318.50 /

-5.53 (-1.71%)

VZIO Vizio
$20.40 /

+0.21 (+1.04%)

Options
Encompass Health options imply 8.1% move in share price post-earnings » 15:19
10/27/21
10/27
15:19
10/27/21
15:19
EHC

Encompass Health

$65.96 /

-1.93 (-2.84%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EHC Encompass Health
$65.96 /

-1.93 (-2.84%)

EHC Encompass Health
$65.96 /

-1.93 (-2.84%)

10/13/21 Truist
Encompass Health price target lowered to $88 from $100 at Truist
09/23/21 UBS
Encompass Health initiated with Buy, $98 target at UBS
09/23/21 UBS
Encompass Health initiated with a Buy at UBS
08/02/21 Raymond James
Encompass Health upgraded to Strong Buy from Outperform at Raymond James
EHC Encompass Health
$65.96 /

-1.93 (-2.84%)

EHC Encompass Health
$65.96 /

-1.93 (-2.84%)

Technical Analysis
NASDAQ market internals summary » 15:17
10/27/21
10/27
15:17
10/27/21
15:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 15:16
10/27/21
10/27
15:16
10/27/21
15:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Hot Stocks
IronNet spikes 37% after announcing joining Microsoft Intelligent Security Assoc » 15:12
10/27/21
10/27
15:12
10/27/21
15:12
IRNT

IronNet

$13.81 /

+3.48 (+33.69%)

, MSFT

Microsoft

$325.37 /

+15.53 (+5.01%)

IronNet (IRNT) jumped 37%…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRNT IronNet
$13.81 /

+3.48 (+33.69%)

MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

IRNT IronNet
$13.81 /

+3.48 (+33.69%)

09/29/21
Fly Intel: Top five analyst initiations
09/29/21 Jefferies
IronNet initiated with a Hold at Jefferies
09/27/21 Needham
IronNet initiated with a Buy at Needham
09/27/21 Needham
IronNet initiated with a Buy at Needham
MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

09:13 Today Wedbush
Microsoft delivers another 'World-Series' cloud performance, says Wedbush
08:41 Today Credit Suisse
Microsoft price target raised to $340 from $320 at Credit Suisse
08:33 Today Morgan Stanley
Microsoft price target raised to $364 from $331 at Morgan Stanley
08:24 Today Evercore ISI
Microsoft price target raised to $370 from $325 at Evercore ISI
MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

IRNT IronNet
$13.81 /

+3.48 (+33.69%)

MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

IRNT IronNet
$13.81 /

+3.48 (+33.69%)

MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

Options
Digimarc options imply 9.4% move in share price post-earnings » 15:11
10/27/21
10/27
15:11
10/27/21
15:11
DMRC

Digimarc

$46.78 /

-1.11 (-2.32%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DMRC Digimarc
$46.78 /

-1.11 (-2.32%)

DMRC Digimarc
$46.78 /

-1.11 (-2.32%)

10/29/20 Craig-Hallum
Digimarc price target raised to $23 from $13 at Craig-Hallum
DMRC Digimarc
$46.78 /

-1.11 (-2.32%)

DMRC Digimarc
$46.78 /

-1.11 (-2.32%)

Recommendations
UBS price target raised to CHF 20 from CHF 19 at RBC Capital » 15:10
10/27/21
10/27
15:10
10/27/21
15:10
UBS

UBS

$18.12 /

+0.16 (+0.89%)

RBC Capital analyst Anke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBS UBS
$18.12 /

+0.16 (+0.89%)

UBS UBS
$18.12 /

+0.16 (+0.89%)

14:59 Today Barclays
UBS price target raised to CHF 16.50 from CHF 15 at Barclays
14:09 Today Credit Suisse
UBS price target raised to CHF 19.50 from CHF 18.50 at Credit Suisse
13:44 Today Deutsche Bank
UBS price target raised to CHF 19 from CHF 18 at Deutsche Bank
10/26/21 DZ Bank
UBS downgraded to Hold from Buy at DZ Bank
UBS UBS
$18.12 /

+0.16 (+0.89%)

UBS UBS
$18.12 /

+0.16 (+0.89%)

UBS UBS
$18.12 /

+0.16 (+0.89%)

Recommendations
Reckitt Benckiser price target lowered to 6.200 GBp at RBC Capital » 15:09
10/27/21
10/27
15:09
10/27/21
15:09
RBGLY

Reckitt Benckiser

$15.96 /

+0.87 (+5.77%)

RBC Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RBGLY Reckitt Benckiser
$15.96 /

+0.87 (+5.77%)

RBGLY Reckitt Benckiser
$15.96 /

+0.87 (+5.77%)

14:57 Today Barclays
Reckitt Benckiser price target lowered to 8,900 GBp from 9,500 GBp at Barclays
10/01/21 UBS
Reckitt Benckiser price target lowered to 7,600 GBp from 8,000 GBp at UBS
09/20/21 Barclays
Reckitt Benckiser price target lowered to 9,500 GBp from 9,800 GBp at Barclays
09/16/21 Deutsche Bank
Reckitt Benckiser named short-term investment idea at Deutsche Bank
Recommendations
HSBC price target raised to 490 GBp from 460 GBp at RBC Capital » 15:09
10/27/21
10/27
15:09
10/27/21
15:09
HSBC

HSBC

$30.51 /

-0.21 (-0.68%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSBC HSBC
$30.51 /

-0.21 (-0.68%)

HSBC HSBC
$30.51 /

-0.21 (-0.68%)

10/26/21 JPMorgan
HSBC price target raised to 450 GBp from 440 GBp at JPMorgan
10/22/21 Investec
HSBC downgraded to Hold from Buy at Investec
10/15/21 Barclays
HSBC price target raised to 550 GBp from 530 GBp at Barclays
10/14/21 BofA
BofA upgrades HSBC to Buy, raises forecasts on recent rate moves
HSBC HSBC
$30.51 /

-0.21 (-0.68%)

HSBC HSBC
$30.51 /

-0.21 (-0.68%)

HSBC HSBC
$30.51 /

-0.21 (-0.68%)

HSBC HSBC
$30.51 /

-0.21 (-0.68%)

Recommendations
Davide Campari-Milano price target raised to EUR 10 at RBC Capital » 15:08
10/27/21
10/27
15:08
10/27/21
15:08
DVDCF

Davide Campari-Milano

$14.40 /

-0.61 (-4.06%)

RBC Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVDCF Davide Campari-Milano
$14.40 /

-0.61 (-4.06%)

DVDCF Davide Campari-Milano
$14.40 /

-0.61 (-4.06%)

14:44 Today Barclays
Davide Campari-Milano price target raised to EUR 12.90 at Barclays
10/14/21 JPMorgan
Davide Campari-Milano price target raised to EUR 14 from EUR 13 at JPMorgan
10/08/21 Barclays
Davide Campari-Milano price target raised to EUR 12.50 from EUR 12 at Barclays
10/05/21 AlphaValue/Baader
Davide Campari-Milano upgraded to Reduce from Sell at AlphaValue/Baader
Recommendations
Alfa Laval price target raised to SEK 400 from SEK 370 at RBC Capital » 15:08
10/27/21
10/27
15:08
10/27/21
15:08
ALFVY

Alfa Laval

$40.25 /

+1.8 (+4.68%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALFVY Alfa Laval
$40.25 /

+1.8 (+4.68%)

09/28/21 Morgan Stanley
Alfa Laval price target raised to SEK 312 from SEK 300 at Morgan Stanley
09/06/21 Credit Suisse
Alfa Laval downgraded to Neutral from Outperform at Credit Suisse
08/03/21 Barclays
Alfa Laval price target raised to SEK 320 from SEK 270 at Barclays
07/22/21 JPMorgan
Alfa Laval price target raised to SEK 310 from SEK 250 at JPMorgan
Options
Sleep Number options imply 9.7% move in share price post-earnings » 15:04
10/27/21
10/27
15:04
10/27/21
15:04
SNBR

Sleep Number

$89.52 /

-1.33 (-1.46%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNBR Sleep Number
$89.52 /

-1.33 (-1.46%)

SNBR Sleep Number
$89.52 /

-1.33 (-1.46%)

07/21/21 Piper Sandler
Sleep Number price target lowered to $135 from $165 at Piper Sandler
02/18/21
Fly Intel: Top five analyst upgrades
02/18/21 Wedbush
Sleep Number price target raised to $130 from $120 at Wedbush
02/18/21 Piper Sandler
Sleep Number price target raised to $165 from $108 at Piper Sandler
SNBR Sleep Number
$89.52 /

-1.33 (-1.46%)

SNBR Sleep Number
$89.52 /

-1.33 (-1.46%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.